Erin Pennock Foff
Chief Medical Officer · MapLight Therapeutics, Inc.
- 2025
- Aug 19, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Erin Pennock Foff files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
- Novo Holdings A/S - $16.20M in MPLT purchases and sales in the last 12 months
- Christopher A. Kroeger - $12.54M in MPLT purchases and sales in the last 12 months
- Jonathan Gillis - $3.56M in MPLT purchases and sales in the last 12 months
- Anatol Kreitzer - $2.78M in MPLT purchases and sales in the last 12 months
- James Woodruff Lillie - $2.56M in MPLT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Erin Pennock Foff?
Erin Pennock Foff is a corporate insider, tracked as Chief Medical Officer of MapLight Therapeutics, Inc. (MPLT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Erin Pennock Foff submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Erin Pennock Foff been buying or selling stock?
Recorded transactions: 0 open-market purchases and 22 open-market sales ($3.38M) across all tracked filings.
